Skip to main content
. 2013 Jan 29;14(1):412–424. doi: 10.1208/s12249-013-9921-9

Table III.

Evaluation of In Situ Nasal Gels of LOR

Formulation code clarity pH Gelling temp (°C) Gelling time (s) Viscosity of sol (cps) Drug content (%) Gel strength (s) Mucoadhesive-strength (dyne/cm2)
F1 Clear 5.75 ± 0.05 33.7 ± 0.47 12.6 ± 0.47 28.34 ± 0.47 77.41 ± 0.40 26.51 ± 0.67 3,626.12 ± 0.34
F2 Clear 5.63 ± 0.01 34.3 ± 0.47 14.6 ± 0.94 27.39 ± 1.25 96.42 ± 0.32 27.82 ± 1.26 3,920.05 ± 0.47
F3 Clear 5.70 ± 0.01 32.6 ± 0.47 10.6 ± 0.94 35.35 ± 0.94 75.21 ± 0.48 33.30 ± 0.94 6,157.67 ± 0.2 3
F4 Clear 5.59 ± 0.01 32.1 ± 0.47 11.3 ± 0.47 34.63 ± 1.24 98.91 ± 0.23 35.61 ± 1.41 6,161.38 ± 0.47
F5 Clear 5.76 ± 0.01 30.7 ± 0.47 8.3 ± 0.47 28.82 ± 0.47 80.32 ± 0.37 38.81 ± 0.87 4,540.61 ± 1.24
F6 Clear 5.64 ± 0.01 30.2 ± 0.23 9.7 ± 0.47 29.09 ± 0.81 92.81 ± 0.54 39.00 ± 0.81 4,847.33 ± 0.46
F7 Clear 5.81 ± 0.01 29.2 ± 0.82 5.7 ± 0.47 43.61 ± 0.47 82.20 ± 0.08 45.61 ± 1.2 7 7,137.64 ± 0.81
F8 Clear 5.34 ± 0.02 28.7 ± 0.47 6.7 ± 0.47 43.36 ± 0.94 97.72 ± 0.59 44.36 ± 0.94 7,676.09 ± 0.97